Study design and early result of a phase I study of SABR for early-stage glottic cancer

The Laryngoscope
Tosol YuEun-Jae Chung

Abstract

Avoidance of organs at risk has become possible with advances in image-guided volumetric-modulated arc therapy (VMAT) techniques. This study was designed to evaluate the safety and feasibility of stereotactic ablative radiotherapy (SABR) for early stage glottic cancer. This report presents the preliminary result of the first and second dose level. Fraction size was increased from 3.5 gray (Gy) (total dose 59.5 Gy) to 9 Gy (total dose 45 Gy). Dose-limiting toxicities were defined as grade 3 or higher treatment-related toxicities. Voice outcome was assessed with electroglottography, and quality of life (QoL) was measured with the Head and Neck Cancer Inventory (HNCI). Seven patients received 59.5 Gy at 3.5 Gy per fraction as the first dose level, and five patients received 55 Gy at 5 Gy per fraction as the second dose level. None of the patients developed grade 3+ toxicity throughout a median follow-up of 17.5 months (range, 1.7-30.6 months). One patient in the second dose level recurred in the primary site at 4 months after radiotherapy (RT) and received total laryngectomy. The rest of participants were disease-free at locoregional and distant sites. Jitter, shimmer, mean phonation time, and noise-to-harmony ratio did not change...Continue Reading

References

Apr 12, 2000·International Journal of Radiation Oncology, Biology, Physics·A RovirosaA Biete
Oct 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W M MendenhallR W Hinerman
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lucille D A DorresteijnHarry Bartelink
Jan 16, 2003·International Journal of Radiation Oncology, Biology, Physics·Adam S GardenK Kian Ang
Jun 17, 2003·Head & Neck·Gerry F FunkJoan Ricks
Sep 16, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Raghavendra V GowdaNicholas J Slevin
Jun 1, 2005·American Journal of Clinical Oncology·Allie Garcia-SerraWilliam M Mendenhall
Jun 28, 2005·International Journal of Radiation Oncology, Biology, Physics·Joseph D MartinJohn H Hay
Sep 20, 2005·International Journal of Radiation Oncology, Biology, Physics·Hideya YamazakiMasashi Chatani
Jul 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN American Society of Clinical OncologyGregory T Wolf
Dec 5, 2006·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Peter ZbärenEdouard Stauffer
Apr 3, 2007·International Journal of Radiation Oncology, Biology, Physics·Giuseppe SanguinetiBrent Parker
Apr 10, 2007·International Journal of Radiation Oncology, Biology, Physics·Ken DornfeldJohn M Buatti
Aug 24, 2007·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Peter C LevendagBen J Heijmen
Feb 2, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Rehan KaziKevin Harrington
May 13, 2008·International Journal of Radiation Oncology, Biology, Physics·Hale B CaglarAaron M Allen
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
May 27, 2009·International Journal of Radiation Oncology, Biology, Physics·Jimmy J CaudellJames A Bonner
Sep 5, 2012·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·A GrecoM de Vincentiis
Feb 18, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Yu Jin LimCharn Il Park
Mar 13, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Kyu-Won JungKang Hyun Lee
Aug 13, 2015·International Journal of Radiation Oncology, Biology, Physics·Abrahim Al-MamganiPeter C Levendag
Apr 23, 2016·Radiation Oncology Journal·Young Suk KimGwi Eon Kim

❮ Previous
Next ❯

Citations

May 2, 2021·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·M TonneauX Liem

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.